Smith & Nephew (SNN) Change in Account Payables (2023 - 2024)
Smith & Nephew (SNN) posted quarterly Change in Account Payables of -$91.0 million for Q4 2024, up 47.09% year-on-year from -$61.9 million in Q1 2024, and up 47.09% on a QoQ basis from -$172.0 million in Q4 2023.
Smith & Nephew (SNN) Change in Account Payables (2023 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Change in Account Payables for 2 consecutive years, with -$91.0 million the latest figure, recorded in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | - |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | 56.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -91.00 Mn |
| Dec 31, 2024 | -91.00 Mn |
| Dec 31, 2023 | -172.00 Mn |
| Dec 31, 2023 | -172.00 Mn |